TD Cowen lowered the firm’s price target on Alphatec (ATEC) to $11 from $20 and keeps a Buy rating on the shares. The firm said sales disappointed, particularly EOS, but Surgical was softer, where numbers typically outperform and were only in line. Margins were strong though, driving a sizable EBITDA beat and allowing for affirmed P&L guidance.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATEC:
